sellModerate
Target N Biotech V sold $846k of MTEM
owner at Molecular Templates, Inc.. 1,279,820 shares at an average of $0.66, traded Nov 14, 2024, filed Nov 18, 2024.
Warning score
55Value
$846k
1,279,820 shares
Holdings after
0
-100% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +12Role10% owner
- +23Trade size$846k at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-128208, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 14, 2024 | SOpen-market sale Common Stock | -1,279,820 | $0.66 | $846k | 0 | Nov 18, 2024 |
| Apr 2, 2024 | POpen-market purchase Prefunded Warrants (right to buy)derivative | +134,667 | $2.35 | $316k | 134,667 | Nov 18, 2024 |
| Apr 2, 2024 | POpen-market purchase Common Warrants (right to buy)derivative | +769,334 | $0.13 | $96k | 769,334 | Nov 18, 2024 |
Related signals
Other insiders at Molecular Templates, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 32Weak | MTEMbuy Molecular Templates, Inc. | Target N Biotech V owner | $588k 250,000 shares | +24% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.